Development of an AAV9-mediated gene therapy for hereditary spastic paraplegia 47

被引：0
|
作者：
Scarrott, J. M. [1 ]
Coldicott, I. [1 ]
Davies, A. [2 ]
Hirst, J. [2 ]
Karyka, E. [1 ]
Bauer, C. [1 ]
Azzouz, M. [1 ]
机构：
[1] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England
[2] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P03
引用
收藏
页码：A18 / A18
页数：1
相关论文
共 50 条
  • [1] Development of an AAV Gene Therapy for Hereditary Spastic Paraplegia Type 4 (SPG4-HSP)
    Hall, Erin F.
    Gallagher, Jillian
    Taghian, Toloo
    McElroy, Abby
    Benatti, Hector Ribeiro
    Prestigiacomo, Rachel
    Bertrand, Stephanie
    Piermarini, Emanuela
    Qiang, Liang
    Baas, Peter
    Sena-Esteves, Miguel
    Gray-Edwards, Heather L.
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 350 - 351
  • [2] AAV9-MEDIATED GENE THERAPY OF CHOLINE ACETYLTRANSFERASE DEFICIENT MICE
    Thomas, Clementine A. D.
    Lin, Cameron C.
    Huynh, Thanh L.
    Wei, David T.
    Vazquez, Jessica
    Maselli, Ricardo A.
    [J]. MUSCLE & NERVE, 2022, 65 : S22 - S23
  • [3] Gene Replacement Therapy for Spastic Paraplegia 47
    Wiseman, J.
    Cruzeiro, J.
    Scarrott, J.
    Karyka, E.
    Marchi, P.
    Webster, C. P.
    Yang, Z.
    Coldicott, I.
    Shaw, P. J.
    Ferraiuolo, L.
    Azzouz, M.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A26 - A27
  • [4] Efficient AAV9-mediated gene delivery to the heart
    Liao Haihan
    Tang, Qizhu
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C18 - C18
  • [5] Development of an Intrathecal AAV9/AP4M1 Gene Therapy for Hereditary Spastic Paraplegia 50 (SPG50)
    Chen, Xin
    Dong, Thomas
    Hu, Yuhui
    De Pace, Raffaella
    Mattera, Rafael
    Eberhardt, Kathrin
    Ziegler, Marvin
    Sahin, Mustafa
    Bonifacino, Juan S.
    Ebrahimi-Fakhari, Darius
    Gray, Steven J.
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 32 - 33
  • [6] AAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patient
    Dowling, James J.
    Pirovolakis, Terry
    Devakandan, Keshini
    Stosic, Ana
    Pidsadny, Mia
    Nigro, Elisa
    Sahin, Mustafa
    Ebrahimi-Fakhari, Darius
    Messahel, Souad
    Varadarajan, Ganapathy
    Greenberg, Benjamin M.
    Chen, Xin
    Minassian, Berge A.
    Cohn, Ronald
    Bonnemann, Carsten G.
    Gray, Steven J.
    [J]. NATURE MEDICINE, 2024, : 1882 - 1887
  • [7] AAV9-Mediated Gene Therapy in a Knock-In Mouse Model of Infantile Neuroaxonal Dystrophy
    Geard, Amy F.
    Whaler, Sammie
    Liu, Wenfei
    Massaro, Giulia
    Hughes, Michael
    Nelvagal, Hemanth
    Poupon-Bejuit, Laura
    Albutt, Jessica
    Lalji, Krushni
    Waddington, Simon
    Kurian, Manju
    Rahim, Ahad A.
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 342 - 342
  • [8] AAV9-mediated gene therapy in a knock-in mouse model of infantile neuroaxonal dystrophy
    Whaler, S.
    Geard, A. F.
    Poupon-Bejuit, L.
    Massaro, G.
    Hughes, M. P.
    Lalji, K.
    Waddington, S. N.
    Kurian, M. A.
    Rahim, A. A.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A12 - A12
  • [9] Hereditary spastic paraplegia gene discovered
    Pistoi, S
    [J]. LANCET, 1998, 351 (9120): : 1936 - 1936
  • [10] AAV-mediated gene therapy treatment of newly generated hereditary spastic paraplegia type 52 (SPG52) mouse model
    Rodriguez-Estevez, L.
    Almolda, B.
    Marco, I.
    Bosch, A.
    Chillon, M.
    Espinosa-Parrilla, J. F.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A86 - A86
12345